Adipose tissue mass can be regulated through the vasculature

Tumor growth is angiogenesis dependent. We hypothesized that nonneoplastic tissue growth also depends on neovascularization. We chose adipose tissue as an experimental system because of its remodeling capacity. Mice from different obesity models received anti-angiogenic agents. Treatment resulted in dose-dependent, reversible weight reduction and adipose tissue loss. Marked vascular remodeling was evident in adipose tissue sections, which revealed decreased endothelial proliferation and increased apoptosis in treated mice compared with controls. Continuous treatment maintained mice near normal body weights for age without adverse effects. Metabolic adaptations in food intake, metabolic rate, and energy substrate utilization were associated with anti-angiogenic weight loss. We conclude that adipose tissue mass is sensitive to angiogenesis inhibitors and can be regulated by its vasculature.

[1]  O. Ishiko,et al.  Angiogenesis in adipose tissues and skeletal muscles with rebound weight-gain after diet-restriction in rabbits. , 2001, International journal of molecular medicine.

[2]  J. Rossant,et al.  Liver Organogenesis Promoted by Endothelial Cells Prior to Vascular Function , 2001, Science.

[3]  Ondine Cleaver,et al.  Induction of Pancreatic Differentiation by Signals from Blood Vessels , 2001, Science.

[4]  B. Cohen,et al.  Leptin Induces Angiopoietin-2 Expression in Adipose Tissues* , 2001, The Journal of Biological Chemistry.

[5]  W. Figg,et al.  TNP-470: an angiogenesis inhibitor in clinical development for cancer , 2000, Expert opinion on investigational drugs.

[6]  J. Henkin,et al.  Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases , 2000, Journal of cellular biochemistry.

[7]  R. D'Amato,et al.  Genetic heterogeneity of angiogenesis in mice , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  E. Scanziani,et al.  BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  P. Hahnfeldt,et al.  Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. , 1999, Cancer research.

[10]  E. Scharrer.  Control of food intake by fatty acid oxidation and ketogenesis. , 1999, Nutrition.

[11]  G. Garcı́a-Cardeña,et al.  Biological action of leptin as an angiogenic factor. , 1998, Science.

[12]  T. Yoshida,et al.  Suppression of hepatoma growth and angiogenesis by a fumagillin derivative TNP470: possible involvement of nitric oxide synthase. , 1998, Cancer research.

[13]  M. Compton,et al.  Brain administration of leptin causes deletion of adipocytes by apoptosis. , 1998, Endocrinology.

[14]  A. Bergh,et al.  Testosterone Stimulates Angiogenesis and Vascular Regrowth in the Ventral Prostate in Castrated Adult Rats. , 1998, Endocrinology.

[15]  J. Folkman.  Editorial: Is Tissue Mass Regulated by Vascular Endothelial Cells? Prostate as the First Evidence. , 1998, Endocrinology.

[16]  Thomas Boehm,et al.  Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.

[17]  H. S. Bayley,et al.  Precision and accuracy of total body bone mass and body composition measurements in the rat using x-ray-based dual photon absorptiometry. , 1997, Canadian journal of physiology and pharmacology.

[18]  J. Friedman,et al.  Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. L. Crandall,et al.  A Review of the Microcirculation of Adipose Tissue: Anatomic, Metabolic, and Angiogenic Perspectives , 1997, Microcirculation.

[20]  E. Kelso,et al.  Effect of Glucose and 2-Deoxyglucose on Hypothalamic GABA Release in Lactating Rats , 1997, Physiology & Behavior.

[21]  T. Rosengart,et al.  Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. , 1997, The Journal of surgical research.

[22]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[23]  R. Kerbel,et al.  Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis. , 1996, European journal of cancer.

[24]  L. Campfield,et al.  The OB Protein (Leptin) Pathway - A Link Between Adipose Tissue Mass and Central Neural Networks , 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[25]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[26]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[27]  T. Morita,et al.  Antitumour effect of a synthetic analogue of fumagillin on murine renal carcinoma. , 1994, British journal of urology.

[28]  K. Wong,et al.  Extracellular matrix components secreted by microvascular endothelial cells stimulate preadipocyte differentiation in vitro. , 1994, Metabolism: clinical and experimental.

[29]  R. D'Amato,et al.  Thalidomide is an inhibitor of angiogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Ingber,et al.  Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). , 1994, British Journal of Cancer.

[31]  C. Christiansen,et al.  Accuracy of measurements of body composition by dual-energy x-ray absorptiometry in vivo. , 1993, The American journal of clinical nutrition.

[32]  K. Brownell,et al.  Early-onset repeated dieting reduces food intake and body weight but not adiposity in dietary-obese female rats , 1992, Physiology & Behavior.

[33]  D. Ingber,et al.  Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. , 1991, Biochemical and biophysical research communications.

[34]  D. Ingber,et al.  Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth , 1990, Nature.

[35]  B. Spiegelman,et al.  1-Butyryl-Glycerol: A novel angiogenesis factor secreted by differentiating adipocytes , 1990, Cell.

[36]  J. Folkman,et al.  Angiogenic activity of adipose tissue. , 1988, Biochemical and biophysical research communications.

[37]  J. Denekamp,et al.  Endothelial proliferation in tumours and normal tissues: continuous labelling studies. , 1984, British Journal of Cancer.

[38]  John E. Harkness,et al.  Biology and Medicine of Rabbits and Rodents , 1983 .

[39]  B. Spiegelman,et al.  Potent stimulation of vascular endothelial cell growth by differentiated 3T3 adipocytes. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[40]  H. Green,et al.  Adipose conversion of 3T3 cells depends on a serum factor. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Thenen,et al.  Effects of Prolonged Fenfluramine Administration in Obese and Nonobese Mice , 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[42]  I. Gersh,et al.  BLOOD VESSELS IN FAT TISSUE. RELATION TO PROBLEMS OF GAS EXCHANGE , 1945, The Journal of experimental medicine.